1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Atopic Dermatitis Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, 2022 & 2032F |
3.3 United Kingdom (UK) Atopic Dermatitis Market - Industry Life Cycle |
3.4 United Kingdom (UK) Atopic Dermatitis Market - Porter's Five Forces |
3.5 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume Share, By Drug Class, 2022 & 2032F |
3.6 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume Share, By Mode Of Administration, 2022 & 2032F |
3.7 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 United Kingdom (UK) Atopic Dermatitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of atopic dermatitis in the UK population |
4.2.2 Growing awareness about atopic dermatitis and its treatment options |
4.2.3 Advancements in technology leading to the development of innovative treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with atopic dermatitis treatments |
4.3.2 Limited access to specialized healthcare providers for atopic dermatitis patients |
4.3.3 Adverse effects of some existing treatment options on patients |
5 United Kingdom (UK) Atopic Dermatitis Market Trends |
6 United Kingdom (UK) Atopic Dermatitis Market, By Types |
6.1 United Kingdom (UK) Atopic Dermatitis Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Drug Class, 2022-2032F |
6.1.3 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By PDE-4 Inhibitor, 2022-2032F |
6.1.4 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Corticosteroids, 2022-2032F |
6.1.5 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Others, 2022-2032F |
6.1.6 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Biologics, 2022-2032F |
6.1.7 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Calcineurin Inhibitors, 2022-2032F |
6.1.8 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Type, 2022-2032F |
6.1.9 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Pimecrolimus, 2022-2032F |
6.1.10 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Pimecrolimus, 2022-2032F |
6.2 United Kingdom (UK) Atopic Dermatitis Market, By Mode Of Administration |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Topical, 2022-2032F |
6.2.3 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Injectable, 2022-2032F |
6.2.4 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Oral, 2022-2032F |
6.3 United Kingdom (UK) Atopic Dermatitis Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.3.3 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.3.4 United Kingdom (UK) Atopic Dermatitis Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 United Kingdom (UK) Atopic Dermatitis Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Atopic Dermatitis Market Export to Major Countries |
7.2 United Kingdom (UK) Atopic Dermatitis Market Imports from Major Countries |
8 United Kingdom (UK) Atopic Dermatitis Market Key Performance Indicators |
8.1 Patient adherence rate to prescribed treatment regimens |
8.2 Number of clinical trials and research studies conducted in the field of atopic dermatitis |
8.3 Rate of adoption of newer, more effective treatment options |
8.4 Percentage of healthcare providers educated on atopic dermatitis management |
8.5 Patient satisfaction levels with the available treatment options |
9 United Kingdom (UK) Atopic Dermatitis Market - Opportunity Assessment |
9.1 United Kingdom (UK) Atopic Dermatitis Market Opportunity Assessment, By Drug Class, 2022 & 2032F |
9.2 United Kingdom (UK) Atopic Dermatitis Market Opportunity Assessment, By Mode Of Administration, 2022 & 2032F |
9.3 United Kingdom (UK) Atopic Dermatitis Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 United Kingdom (UK) Atopic Dermatitis Market - Competitive Landscape |
10.1 United Kingdom (UK) Atopic Dermatitis Market Revenue Share, By Companies, 2025 |
10.2 United Kingdom (UK) Atopic Dermatitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |